to experience the full functionality of mail.com.
Enhanced by Google
April 29, 2016
Valeant files overdue financial report, ending debt default
Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S.
April 27, 2016
Lawmakers blast Valeant for price-gouging tactics
Lawmakers accused Valeant Pharmaceuticals of gouging patients to reward Wall Street investors during a hearing Wednesday ...
April 26, 2016
Senate hearing into Valeant includes top hedge fund investor
Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the ...
April 25, 2016
Valeant Pharma picks Perrigo leader to become next CEO
Embattled drugmaker Valeant Pharmaceuticals has chosen Perrigo Co. Chairman and CEO Joseph C. Papa to become its new CEO, ...
April 13, 2016
Valeant CEO agrees to be deposed in Senate drug price probe
The chief executive of embattled Valeant Pharmaceuticals, J. Michael Pearson, has agreed to be deposed by a Senate committee ...
March 28, 2016
Valeant share plunge after CEO subpoenaed by Congress
Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals plunged again Monday after its CEO was subpoenaed by a ...
March 24, 2016
CEO of investment firm burned by Valeant stake is retiring
The CEO of the investment firm with the largest stake in troubled Valeant Pharmaceuticals is retiring after the firm suffered ...
March 21, 2016
US stocks drift in early trading; Starwood up on deal news
Stocks are off to a mixed start as the market comes off its fifth straight week of gains. Banks and technology companies were ...
March 21, 2016
Valeant to replace CEO, adds activist investor to board
The CEO of Valeant Pharmaceuticals is leaving, a director has resigned, and the embattled drug company wants another director ...
March 15, 2016
Valeant shocks with missed 4Q results, slashed 2016 guidance
Shares of Valeant Pharmaceuticals crashed Tuesday after the embattled drugmaker failed to reassure investors that it's ...
March 09, 2016
Valeant Pharma adds hedge fund executive, 2 others to board
Embattled drug company Valeant Pharmaceuticals has added three directors to its board, including an executive from activist ...
March 03, 2016
Herbalife overstated member growth, cites database errors
Herbalife, the seller of supplements and weight-loss products currently under federal investigation as a potential pyramid ...
December 16, 2015
Canadian Pacific sweetens offer to buy Norfolk Southern
Canadian Pacific is increasing its offer to buy Norfolk Southern railroad by adding a payment that would vary depending on ...
December 14, 2015
Correction: Dow-DuPont-Activist Investors story
In a story Dec. 11 about activist investors, The Associated Press reported erroneously the name of a Columbia Law professor.
December 08, 2015
Norfolk Southern slams revised offer from Canadian Pacific
Norfolk Southern rejected Canadian Pacific's latest takeover offer less than an hour after it was announced Tuesday, but the ...